Trial Profile
Accuracy of PET imaging with gallium-68 prostate-specific membrane antigen (gallium 68 PSMA) [68Ga-HBED-PSMA] for staging of lymph node involvement in patients with primary prostate cancer
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 15 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.